Tigris Pharmaceuticals Salary

Tigris Pharmaceuticals average salary is $-, median salary is $- with a salary range from $- to $-.
Tigris Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Tigris Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.

Low: -

Average: -

Median: -

High: -

Tigris Pharmaceuticals Jobs

Job Title

Salaries

City

Year

More Info

Tigris Pharmaceuticals Jobs

Today’s New Jobs Immediate job opening
Only $100K+ Jobs Require free registration. Manager, Director, VP, C-level Jobs

Calculate how much you could earn

It's FREE. Based on your input and our analysis. How we do it?

All fields are required for calculation accuracy.

Employer
Job Title
City
Experience
Email
We will send you an email to access your personalized report.
We won’t share your email address

Recent Tigris Pharmaceuticals Salaries (May 22, 2012)

Budget Analyst	K & H Subway	$49,920	Los Angeles, CA, 90001	08/31/2010
Software Development Engineer In Test	Microsoft	$90,000	Redmond, WA, 98052	08/26/2010

Tigris Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List

8.5 million company & government reported salaries with date & location
Salary calculator rank & calculate your salary
151 million W-2s pay scale statistics in U.S.

Related Tigris Pharmaceuticals Salary

Tigris Pharmaceuticals Information

Tigris Pharmaceuticals, Inc
Industry: BioTech/Drugs
City: Bonita Springs, FL
Tigris Pharmaceuticals, Inc. is a venture-backed clinical-stage biopharmaceutical company that commercially develops innovative products for the treatment of important unmet medical needs in cancer and infectious diseases. Tigris is focusing its efforts on the development, testing and commercialization of its lead compound, A-007, as a non-invasive treatment for both pre-cancerous HPV-induced lesions and for invasive epithelial cancers. A key component of Tigris' strategy is to acquire global rights to additional product candidates in oncology and infectious diseases, while continuing to us...
Tigris Pharmaceuticals, Inc Profile
Edmundo Muniz